Array BioPharma Inc. (Nasdaq: ARRY) reversed year ago losses of 20 cents per diluted share to post a stronger than expected profit for the third quarter of 37 cents per diluted share sending the stock price up 82 cents to close at $7.14.
Array reverses losses
May 04, 2015 at 17:22 PM EDT